| Alert ID |
Market |
Published |
Alert (abbreviated) |
Priority |
Impact Category |
Action |
Confidence |
| SB-2026-073 |
Spain |
5/27/2026 |
Launch of RECOPS, the New Application for the Marketing |
P0 |
Conditional logic or pathway u |
Implement |
High |
| SB-2026-081 |
United States |
5/28/2026 |
Content of Human Factors Information in Medical Device |
P0 |
Existing wizard content update |
Implement |
High |
| SB-2026-086 |
United States |
6/1/2026 |
eSTAR Program |
P0 |
Existing wizard content update |
Implement |
High |
| SB-2026-001 |
Malaysia |
5/1/2026 |
Joint Announcement by Medical Device Authority (MDA) Ma |
P1 |
Conditional logic or pathway u |
Monitor |
Medium |
| SB-2026-002 |
Turkey |
5/4/2026 |
Mandatory Use of the EUDAMED Database System (Law No. 2 |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-007 |
Australia |
5/4/2026 |
Accessing and using the AusUDID |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-008 |
Australia |
5/4/2026 |
AusUDID submission methods |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-009 |
Australia |
5/4/2026 |
Accessing the AusUDID |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-010 |
Australia |
5/4/2026 |
AusUDID data elements |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-011 |
Saudi Arabia |
5/5/2026 |
Guidance on Bundling Criteria for Medical Devices withi |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-014 |
Spain |
5/4/2026 |
The AEMPS Updates the Information on the Medical Device |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-016 |
European Union |
5/5/2026 |
Implementing Regulation (EU) 2026/977 – Uniform Require |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-017 |
Denmark |
5/5/2026 |
Medical Devices with Incorporated Drug |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-020 |
Saudi Arabia |
5/5/2026 |
SFDA Medical Devices Forms Updates |
P1 |
Official form/source-template |
Implement |
High |
| SB-2026-021 |
Turkey |
5/7/2026 |
TCOKKA - Publication of Implementing Regulation (EU) 20 |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-022 |
Australia |
5/11/2026 |
Using assessments from comparable overseas regulators f |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-023 |
Australia |
5/11/2026 |
Use of market authorisation evidence from comparable ov |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-024 |
Switzerland |
5/10/2026 |
Swissdamed User Manual Actors |
P1 |
Existing wizard content update |
Implement |
High |
| SB-2026-026 |
Algeria |
5/11/2026 |
Note No. 42 to Pharmaceutical Establishment Relating to |
P1 |
Existing wizard content update |
Compare |
Low |
| SB-2026-028 |
Egypt |
5/14/2026 |
Regulatory Guideline on Requirements for Unique Device |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-030 |
Nicaragua |
5/13/2026 |
New Importation/Exportation Form |
P1 |
Official form/source-template |
Implement |
High |
| SB-2026-033 |
United Kingdom |
5/13/2026 |
Medical Devices: Conformity Assessment and the UKCA Mar |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-035 |
Bahrain |
5/13/2026 |
Launch of TATABU Medical Devices & Supplies Traceabilit |
P1 |
New wizard or coverage-gap ass |
Monitor |
Medium |
| SB-2026-037 |
Malaysia |
5/15/2026 |
Requirements for Labelling of Medical Devices |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-038 |
Malaysia |
5/15/2026 |
Change Management for Registered Medical Devices |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-039 |
Ecuador |
5/18/2026 |
ARCSA has published Resolution ARCSA-DE-2026-003-DASP - |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-041 |
Nicaragua |
5/15/2026 |
User Guide for Requesting the Issuance of a Registratio |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-042 |
Nicaragua |
5/15/2026 |
New Official Request Form for Health Registration Certi |
P1 |
Official form/source-template |
Implement |
High |
| SB-2026-043 |
Vietnam |
5/15/2026 |
Notice on Domain Change for the Online Public Service P |
P1 |
Instructions/reference update |
Implement |
High |
| SB-2026-046 |
United Kingdom |
5/14/2026 |
Clinical Investigations for Medical Devices |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-047 |
Serbia |
5/15/2026 |
New Conditions and Methods of Recognition of Foreign Do |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-048 |
Serbia |
5/15/2026 |
New Conditions and Methods of Recognition of Foreign Ce |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-049 |
Serbia |
5/15/2026 |
New Conditions and Methods of Recognition of Foreign Do |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-050 |
Serbia |
5/15/2026 |
New Conditions and Methods of Recognition of Foreign Ce |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-051 |
Serbia |
5/15/2026 |
Instructions for Submitting a Request for Amendment/Add |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-052 |
Czech Republic |
5/18/2026 |
Application for Authorization to place a Medical Device |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-053 |
Mexico |
5/19/2026 |
Cofepris has published Mexican Official Standard NOM-13 |
P1 |
Existing wizard content update |
Implement |
High |
| SB-2026-060 |
Peru |
5/21/2026 |
DIGEMID has published Ministerial Resolution No. 193-20 |
P1 |
Existing wizard content update |
Compare |
Low |
| SB-2026-062 |
Australia |
5/22/2026 |
Complying with the Unique Device Identification timefra |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-065 |
Czech Republic |
5/18/2026 |
Methodological Instructions for Submitting an Applicati |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-066 |
Sweden |
5/25/2026 |
Regulations (HSLF-FS 2026:11) amending the Medical Prod |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-067 |
Portugal |
5/20/2026 |
Operationalization of EUDAMED on May 28, 2026 |
P1 |
Instructions/reference update |
Compare |
High |
| SB-2026-074 |
Denmark |
5/27/2026 |
Distributor and Specialist Store Registration |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-076 |
Denmark |
5/28/2026 |
Registration in Eudamed |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-077 |
Czech Republic |
5/27/2026 |
Temporary Retention of FSC Applications through RZPRO |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-082 |
Belgium |
5/28/2026 |
EUDAMED: Clarifications Regarding Obligations as of 28 |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-083 |
Slovenia |
5/13/2026 |
Q&A Education May 13, 2026: Obligations of Distributors |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-084 |
Brazil |
6/1/2026 |
Guidance: Importation via DUIMP_v1.9 |
P1 |
Instructions/reference update |
Compare |
High |
| SB-2026-087 |
Czech Republic |
6/1/2026 |
Methodological Guideline for the Implementation of MDR |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-089 |
Oman |
6/3/2026 |
Requirements for Approval of Optical Companies Applying |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-091 |
Switzerland |
6/2/2026 |
Swissdamed Business Rules |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-092 |
Uzbekistan |
5/27/2026 |
New legislative changes will come into force in Uzbekis |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-094 |
Singapore |
6/2/2026 |
GN-12-1: Guidance on Grouping of Medical Devices for Pr |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-095 |
South Africa |
6/4/2026 |
Regulatory Requirements for Medical Devices Electronic |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-097 |
Germany |
5/28/2026 |
European Database for Medical Devices: EUDAMED |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-098 |
Germany |
5/28/2026 |
May 28, 2026: Initial and Amendment Notification MP and |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-100 |
Srilanka |
5/21/2026 |
Reissuance of Sample Import License (SIL)-Medical Devic |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-101 |
Srilanka |
5/21/2026 |
Checklist for Document Accepting of Consolidated new Me |
P1 |
Official form/source-template |
Implement |
High |
| SB-2026-102 |
Algeria |
5/13/2026 |
Guidelines for Regulatory Trust (Reliance) and Recognit |
P1 |
Conditional logic or pathway u |
Compare |
Medium |
| SB-2026-105 |
Lebanon |
6/9/2026 |
Circular No. 23 Regarding FDA-Approved Implantable Medi |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-107 |
Germany |
6/9/2026 |
Self-declaration Regarding the Implementation of the Re |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-108 |
Latvia |
5/28/2026 |
EUDAMED, The European Database for Medical Devices, Lau |
P1 |
Instructions/reference update |
Compare |
Low |
| SB-2026-109 |
Luxembourg |
5/28/2026 |
Mandatory use of EUDAMED from May 28, 2026 |
P1 |
Instructions/reference update |
Compare |
Low |
| SB-2026-112 |
China |
6/1/2026 |
China NMPA Issues Announcement on Medical Device Classi |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-115 |
Hungary |
6/10/2026 |
Deviation from Conformity Assessment Procedures |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-116 |
Hungary |
6/10/2026 |
Conformity Assessment Bodies |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-117 |
United Kingdom |
6/11/2026 |
Regulation of Medical Devices in Northern Ireland |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-118 |
Korea |
6/10/2026 |
Labeling Guideline for Digital Medical Devices |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-120 |
Hong Kong |
6/12/2026 |
GN-02: Guidance Notes for Listing Class II/III/IV Gener |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-121 |
Hong Kong |
6/12/2026 |
GN-06: Guidance Notes for Listing Class B/C/D In Vitro |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-122 |
Brazil |
6/12/2026 |
ANVISA Expands Support and Improvement Measures to Supp |
P1 |
Instructions/reference update |
Compare |
High |
| SB-2026-123 |
Kyrgyzstan |
6/8/2026 |
On Amendments to the Resolution of the Cabinet of Minis |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-125 |
Mexico |
6/17/2026 |
Cofepris has published an update to the Guide to Requir |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-127 |
Canada |
6/17/2026 |
Phase 2 of our Work to Modernize Medical Device Establi |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-129 |
Belarus |
6/16/2026 |
Transfer of Medical Device Regulatory Functions in Bela |
P1 |
Existing wizard content update |
Implement |
High |
| SB-2026-130 |
Switzerland |
6/18/2026 |
Swissdamed User Manual Actors |
P1 |
Existing wizard content update |
Implement |
High |
| SB-2026-131 |
Rwanda |
6/18/2026 |
Regulations Governing Good Manufacturing Practices of M |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-132 |
Botswana |
6/18/2026 |
BOMRA Medical Devices, including IVDs, Regulatory Updat |
P1 |
New wizard or coverage-gap ass |
Monitor |
Medium |
| SB-2026-133 |
Switzerland |
6/19/2026 |
New Options for Product Registration in Swissdamed: Onl |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-137 |
Switzerland |
6/19/2026 |
User Manual Swissdamed UDI Device Module |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-140 |
European Union |
6/18/2026 |
MDCG Position Paper: Management of SS(C)P in EUDAMED af |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-142 |
Mexico |
6/22/2026 |
Update on the Reliance Regulatory Fast Track Platform |
P1 |
Conditional logic or pathway u |
Compare |
Medium |
| SB-2026-143 |
Korea |
6/23/2026 |
Enforcement Decree of the Medical Device Act |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-146 |
Australia |
6/24/2026 |
Complying with the Unique Device Identification timefra |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-147 |
Australia |
6/24/2026 |
Unique Device Identification Consent to Supply process |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-151 |
Kazakhstan |
6/24/2026 |
Law of Kazakhstan On Amendments and Supplements to Cer |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-152 |
South Africa |
6/25/2026 |
Communication on Research Use Only (RUO) and Investigat |
P1 |
Official form/source-template |
Implement |
High |
| SB-2026-154 |
China |
6/23/2026 |
China's NMPA Issues 2026 Revised Registration Review Gu |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-155 |
China |
6/18/2026 |
China's NMPA Releases Technical Review Guidelines for V |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-156 |
China |
6/15/2026 |
China's NMPA Issues Trial Technical Review Guidelines f |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-157 |
India |
6/24/2026 |
Sale of In-Vitro Fertilization Media, Reagents, and Rel |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-158 |
Korea |
6/23/2026 |
Enforcement Decree of the Medical Device Act |
P1 |
Existing wizard content update |
Compare |
High |
| SB-2026-160 |
Brazil |
6/25/2026 |
TECHNICAL NOTE Nº 41/2026/SEI/GQUIP/GGTPS/DIRE3/ANVISA |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-161 |
Korea |
6/26/2026 |
Approval and Review Guideline for Digital Medical Devic |
P1 |
Conditional logic or pathway u |
Compare |
High |
| SB-2026-162 |
Kyrgyzstan |
6/18/2026 |
On Amendments to the Resolution of the Government of th |
P1 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-163 |
Oman |
6/28/2026 |
Extension of Registration Period for High-Risk Medical |
P1 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-164 |
Malaysia |
6/1/2026 |
Malaysia MDA: Fully Online Product Classification Appli |
P1 |
Conditional logic or pathway u |
Implement |
High |
| SB-2026-003 |
Mexico |
5/4/2026 |
Cofepris has published the “Agreement establishing meas |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-004 |
Mexico |
5/4/2026 |
Cofepris has published the “Agreement Updating the Meth |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-005 |
Iraq |
5/6/2026 |
Circular to Scientific Offices and Companies |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-012 |
Chile |
5/7/2026 |
Exempt Resolution No. 2.050/2026 approves the “Guidelin |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-013 |
Chile |
5/6/2026 |
ISP Announces New Certification Program for Domestic an |
P2 |
New wizard or coverage-gap ass |
Monitor |
Medium |
| SB-2026-015 |
United States |
5/6/2026 |
Patient-Matched Guides for Orthopedic Implants |
P2 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-018 |
Switzerland |
5/1/2026 |
Manufacturer Incident Report Guideline |
P2 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-019 |
Switzerland |
5/1/2026 |
Information Sheet Combined Studies |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-025 |
Algeria |
5/10/2026 |
Note No. 41 to Pharmaceutical Establishment and Economi |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-027 |
Hong Kong |
5/13/2026 |
GN-00: Definitions and Abbreviations for the Medical De |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-029 |
Turkey |
5/13/2026 |
Guidelines for Registration Processes of Medical Device |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-031 |
Paraguay |
5/13/2026 |
DINAVISA has published Resolution No. 189/2026 |
P2 |
Existing wizard content update |
Compare |
Low |
| SB-2026-032 |
United Kingdom |
5/11/2026 |
MHRA invites Views on Proposed Changes to Medical Devic |
P2 |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-034 |
Finland |
5/11/2026 |
Medical Device Manufacturers must report Serious Incide |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-036 |
Australia |
5/12/2026 |
Preparing for an application audit for in-vitro diagnos |
P2 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-040 |
Peru |
5/15/2026 |
DIGEMID - Announcement No. 006/2026 |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-044 |
China |
5/8/2026 |
China NMPA Issues Guidance on Registration Review for P |
P2 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-045 |
Ireland |
5/13/2026 |
Guide to Pre-submission Scientific and Regulatory Advic |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-059 |
Mexico |
5/21/2026 |
Guidelines for promoting National Investment in the pro |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-061 |
Kazakhstan |
5/19/2026 |
Order of the Minister of Health of the Republic of Kaza |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-063 |
Australia |
5/12/2026 |
Preparing for an application audit for in-vitro diagnos |
P2 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-068 |
Korea |
5/26/2026 |
Approval and Review Procedures for New Technology Medic |
P2 |
Existing wizard content update |
Compare |
Medium |
| SB-2026-069 |
Switzerland |
5/26/2026 |
Template Trend Report |
P2 |
Official form/source-template |
Compare |
Medium |
| SB-2026-070 |
Switzerland |
5/26/2026 |
Template PSR Report |
P2 |
Official form/source-template |
Compare |
Medium |
| SB-2026-071 |
South Africa |
5/26/2026 |
Guideline on How to Respond to a GMP, GWP, GCP or GVP I |
P2 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-072 |
Korea |
5/28/2026 |
FAQs for Medical Device Non-clinical Trials Guidance |
P2 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-075 |
Denmark |
5/28/2026 |
Registration |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-078 |
Cameroon |
5/29/2026 |
Implementation of a combined Individual Case Safety Rep |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-079 |
Iraq |
5/31/2026 |
Announcement from the Pharmacy Department, Private Sect |
P2 |
Instructions/reference update |
Monitor |
Low |
| SB-2026-080 |
Singapore |
5/28/2026 |
How Medical Devices are Regulated by HSA and their Safe |
P2 |
Instructions/reference update |
Monitor |
Low |
| SB-2026-085 |
Argentina |
6/1/2026 |
Update on fees for ANMAT procedures |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-088 |
Syria |
6/3/2026 |
Regulatory Decision 8/T |
P2 |
Watchlist—draft or unverified |
Escalate |
Low |
| SB-2026-090 |
Iraq |
6/3/2026 |
Circular No. 9/2/1163 To All Scientific Offices and Nat |
P2 |
Instructions/reference update |
Monitor |
Low |
| SB-2026-093 |
Uzbekistan |
5/5/2026 |
On measures to provide additional support to the privat |
P2 |
Watchlist—draft or unverified |
Monitor |
Low |
| SB-2026-096 |
Uzbekistan |
5/25/2026 |
Departmental regulatory legal act on the procedure for |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-099 |
United States |
6/5/2026 |
Intent to Exempt Certain Unclassified Medical Devices f |
P2 |
Conditional logic or pathway u |
Monitor |
Medium |
| SB-2026-106 |
Switzerland |
6/8/2026 |
Swissdamed Machine-to-Machine REST API Technical Docume |
P2 |
Export/XML/data-mapping update |
Monitor |
Medium |
| SB-2026-124 |
China |
6/5/2026 |
China’s NMPA Announces Removal of 10 Medical Device Ind |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-126 |
Peru |
6/17/2026 |
Announcement No. 008/2026 - Webinar on the Medical Devi |
P2 |
Instructions/reference update |
Monitor |
Low |
| SB-2026-128 |
Saudi Arabia |
6/18/2026 |
Standard Specification Annex No. (1) of the Technical R |
P2 |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-134 |
Switzerland |
6/19/2026 |
Amendment to the Swissmedic Fee Ordinance as of July 1, |
P2 |
Instructions/reference update |
Compare |
Medium |
| SB-2026-135 |
Switzerland |
6/19/2026 |
Procurement of Medical Devices in Healthcare Facilities |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-136 |
Switzerland |
6/19/2026 |
Swissdamed User Guide - Playground |
P2 |
Instructions/reference update |
Monitor |
Low |
| SB-2026-138 |
Sweden |
6/17/2026 |
The Swedish Medicines Agency will be responsible for AI |
P2 |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-139 |
European Union |
6/17/2026 |
Guidance on standardisation for medical devices |
P2 |
Instructions/reference update |
Monitor |
Medium |
| SB-2026-141 |
Bahrain |
6/9/2026 |
Updated Fee Schedules of Services and Requests for Medi |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-144 |
Australia |
6/22/2026 |
New UDI Newsletter |
P2 |
Instructions/reference update |
Monitor |
Low |
| SB-2026-145 |
Australia |
6/22/2026 |
Getting started with UDI |
P2 |
Instructions/reference update |
Compare |
Low |
| SB-2026-159 |
Bolivia |
6/25/2026 |
CIRCULAR-22-2026 |
P2 |
Manual technical review |
Escalate |
Low |
| SB-2026-006 |
China |
5/6/2026 |
NMPA Seeks Public Comments on Three Medical Device Regi |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-054 |
Kazakhstan |
5/19/2026 |
Resolution of the Government of the Republic of Kazakhs |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Low |
| SB-2026-055 |
Kazakhstan |
5/19/2026 |
On Amendments to the Order of the Minister of Health of |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-056 |
China |
5/12/2026 |
China Seeks Public Comment on Draft Registration Review |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-057 |
China |
5/11/2026 |
China Seeks Public Comment on Draft Registration Review |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-058 |
China |
5/6/2026 |
China Releases Draft Guidance for Public Comment on Thr |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-064 |
Kazakhstan |
5/22/2026 |
On amendments and additions to the joint order of the M |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Low |
| SB-2026-103 |
Nicaragua |
6/8/2026 |
Public Consultation 175 - (NTON) 24001 |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-110 |
China |
6/3/2026 |
China NMPA Seeks Public Input on Four Draft Medical Dev |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-111 |
China |
6/10/2026 |
China NMPA Opens Public Consultation on Draft Registrat |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-114 |
Kazakhstan |
6/10/2026 |
On amendments to the order of the Minister of Health of |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-119 |
Korea |
6/12/2026 |
Medical Device Manufacturing and Quality Control Standa |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Medium |
| SB-2026-148 |
Brazil |
6/23/2026 |
ANVISA Opens Public Call for Proposals to Improve Techn |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Low |
| SB-2026-150 |
Kyrgyzstan |
6/25/2026 |
Government's Decree |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Low |
| SB-2026-153 |
China |
6/17/2026 |
China's NMPA Invites Industry Participation in Drafting |
Watchlist |
Watchlist—draft or unverified |
Monitor |
Low |
| SB-2026-104 |
Lebanon |
6/9/2026 |
Circular No. 22 Regarding the Entry of Import Invoices |
No SB action |
No SB impact |
Close |
High |
| SB-2026-113 |
Singapore |
6/11/2026 |
Mean Applicant Screening Response Time Audiences |
No SB action |
No SB impact |
Close |
High |
| SB-2026-149 |
Denmark |
6/18/2026 |
Fees for Clinical Trials of Medical Devices |
No SB action |
No SB impact |
Close |
High |